As part of the Supportive Care Knowledge Dissemination in Pediatric Oncology webinar series, SIOP invites members to an educational session focused on improving outcomes in one of the most impactful treatment-related toxicities in pediatric oncology.

Webinar Title

Achieving Complete Control of Chemotherapy‑Induced Nausea and Vomiting

Date & Time

  • Wednesday, May 21, 2026
  • 14:00 CEST/Geneva

Register Now (SIOP username and password required)

About the Webinar

Chemotherapy‑induced nausea and vomiting (CINV) remain among the most distressing side effects of cancer treatment for children and adolescents, significantly affecting quality of life and treatment adherence.

In this educational webinar, participants will:

  • Understand the evidence base underpinning current clinical practice guidelines for CINV management
  • Learn about key barriers to achieving complete control of CINV and practical strategies to overcome them
  • Hear about emerging and innovative interventions currently being evaluated to improve CINV prevention and management

This session is designed for healthcare professionals involved in pediatric oncology care who wish to strengthen their knowledge and translate supportive care evidence into clinical practice.

Speaker

Lee Dupuis, RPh, ACPR, MScPhm, FCSHP, PhD
Senior Associate Scientist, Research Institute
Health Clinician Scientist, Department of Pharmacy
Clinical Pharmacist, Haematology/Oncology/Blood and Marrow Transplant/Cellular Therapy
The Hospital for Sick Children (SickKids), Toronto, Canada

Professor and Co‑Lead, MScPhm Program
Leslie Dan Faculty of Pharmacy, University of Toronto

Dr. Lee Dupuis is an internationally recognized leader in pediatric oncology supportive care. She holds leadership roles within the Children’s Oncology Group and the Pediatric Oncology Group of Ontario, and is the Co‑Founder and Co‑Director of the international Pediatric Oncology Supportive Care Guideline Network (iPOG Network).

Her research program focuses on optimizing supportive care for children receiving cancer therapy or hematopoietic cell transplant/cellular therapy. Her work centers on enhancing symptom communication by children, evaluating interventions to manage treatment‑related toxicity, and advancing the development, implementation, and uptake of supportive care clinical practice guidelines.